To this end, CSF1R+ macrophages were previously shown to be required for the development of hepatic lesions marked by fibrin thrombi that form in tumor-bearing mice in response to anti-CD40 in combination with gemcitabine chemotherapy (21). The gene discussed is CD40; the disease is neoplasm.